The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nanobody Discovery Service Market Research Report 2025
Synopsis
Nanobody discovery service is a nanobody-based technology for screening and discovering nanobodies with high affinity and specificity. Nanobodies are natural single-chain antibodies that exist in the serum of camelids and sharks . Compared with traditional antibodies, nanobodies have the advantages of small molecular weight, good stability, and strong tissue penetration ability. Because they have no light chain structure, they can be flexibly combined with various antibody molecules. They are used in bispecific antibody drugs and cell therapy drugs. It has broad application prospects in the field of disease diagnosis and treatment, such as diagnosis and detection.
Global Nanobody Discovery Service market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nanobody Discovery Service market research.
Key companies engaged in the Nanobody Discovery Service industry include Creative Biolabs, Curia, Sanofi, NanoTag Biotechnologies, Shanghai Medicilon Inc., Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Yeasen Biotechnology（Shanghai）Co.,Ltd., Fortis Life Sciences and Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Nanobody Discovery Service were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nanobody Discovery Service market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nanobody Discovery Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Creative Biolabs
Curia
Sanofi
NanoTag Biotechnologies
Shanghai Medicilon Inc.
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Yeasen Biotechnology（Shanghai）Co.,Ltd.
Fortis Life Sciences
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Biointron Biological Inc.
SAFE Pharmaceutical Technology Co., Ltd.
Abterra Biosciences
Chengdu Apak Biotechnology Co., Ltd.
ICarTab Biomedical Co., Ltd.
Wuhan Daian Biotech Ltd
Segment by Type
Screening and Development Services
Engineering and Optimization Services
Production and Expression Services
Other Services
Segment by Application
Drug Discovery
Biological Engineering
Clinical Diagnosis
Immune Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nanobody Discovery Service report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Nanobody discovery service is a nanobody-based technology for screening and discovering nanobodies with high affinity and specificity. Nanobodies are natural single-chain antibodies that exist in the serum of camelids and sharks . Compared with traditional antibodies, nanobodies have the advantages of small molecular weight, good stability, and strong tissue penetration ability. Because they have no light chain structure, they can be flexibly combined with various antibody molecules. They are used in bispecific antibody drugs and cell therapy drugs. It has broad application prospects in the field of disease diagnosis and treatment, such as diagnosis and detection.
Global Nanobody Discovery Service market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nanobody Discovery Service market research.
Key companies engaged in the Nanobody Discovery Service industry include Creative Biolabs, Curia, Sanofi, NanoTag Biotechnologies, Shanghai Medicilon Inc., Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Yeasen Biotechnology（Shanghai）Co.,Ltd., Fortis Life Sciences and Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Nanobody Discovery Service were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nanobody Discovery Service market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nanobody Discovery Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Creative Biolabs
Curia
Sanofi
NanoTag Biotechnologies
Shanghai Medicilon Inc.
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Yeasen Biotechnology（Shanghai）Co.,Ltd.
Fortis Life Sciences
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Biointron Biological Inc.
SAFE Pharmaceutical Technology Co., Ltd.
Abterra Biosciences
Chengdu Apak Biotechnology Co., Ltd.
ICarTab Biomedical Co., Ltd.
Wuhan Daian Biotech Ltd
Segment by Type
Screening and Development Services
Engineering and Optimization Services
Production and Expression Services
Other Services
Segment by Application
Drug Discovery
Biological Engineering
Clinical Diagnosis
Immune Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nanobody Discovery Service report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanobody Discovery Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Screening and Development Services
1.2.3 Engineering and Optimization Services
1.2.4 Production and Expression Services
1.2.5 Other Services
1.3 Market by Application
1.3.1 Global Nanobody Discovery Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Discovery
1.3.3 Biological Engineering
1.3.4 Clinical Diagnosis
1.3.5 Immune Research
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanobody Discovery Service Market Perspective (2018-2029)
2.2 Nanobody Discovery Service Growth Trends by Region
2.2.1 Global Nanobody Discovery Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nanobody Discovery Service Historic Market Size by Region (2018-2023)
2.2.3 Nanobody Discovery Service Forecasted Market Size by Region (2024-2029)
2.3 Nanobody Discovery Service Market Dynamics
2.3.1 Nanobody Discovery Service Industry Trends
2.3.2 Nanobody Discovery Service Market Drivers
2.3.3 Nanobody Discovery Service Market Challenges
2.3.4 Nanobody Discovery Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanobody Discovery Service Players by Revenue
3.1.1 Global Top Nanobody Discovery Service Players by Revenue (2018-2023)
3.1.2 Global Nanobody Discovery Service Revenue Market Share by Players (2018-2023)
3.2 Global Nanobody Discovery Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanobody Discovery Service Revenue
3.4 Global Nanobody Discovery Service Market Concentration Ratio
3.4.1 Global Nanobody Discovery Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanobody Discovery Service Revenue in 2022
3.5 Nanobody Discovery Service Key Players Head office and Area Served
3.6 Key Players Nanobody Discovery Service Product Solution and Service
3.7 Date of Enter into Nanobody Discovery Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanobody Discovery Service Breakdown Data by Type
4.1 Global Nanobody Discovery Service Historic Market Size by Type (2018-2023)
4.2 Global Nanobody Discovery Service Forecasted Market Size by Type (2024-2029)
5 Nanobody Discovery Service Breakdown Data by Application
5.1 Global Nanobody Discovery Service Historic Market Size by Application (2018-2023)
5.2 Global Nanobody Discovery Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nanobody Discovery Service Market Size (2018-2029)
6.2 North America Nanobody Discovery Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nanobody Discovery Service Market Size by Country (2018-2023)
6.4 North America Nanobody Discovery Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanobody Discovery Service Market Size (2018-2029)
7.2 Europe Nanobody Discovery Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nanobody Discovery Service Market Size by Country (2018-2023)
7.4 Europe Nanobody Discovery Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanobody Discovery Service Market Size (2018-2029)
8.2 Asia-Pacific Nanobody Discovery Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nanobody Discovery Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Nanobody Discovery Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanobody Discovery Service Market Size (2018-2029)
9.2 Latin America Nanobody Discovery Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nanobody Discovery Service Market Size by Country (2018-2023)
9.4 Latin America Nanobody Discovery Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanobody Discovery Service Market Size (2018-2029)
10.2 Middle East & Africa Nanobody Discovery Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nanobody Discovery Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Nanobody Discovery Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Detail
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Nanobody Discovery Service Introduction
11.1.4 Creative Biolabs Revenue in Nanobody Discovery Service Business (2018-2023)
11.1.5 Creative Biolabs Recent Development
11.2 Curia
11.2.1 Curia Company Detail
11.2.2 Curia Business Overview
11.2.3 Curia Nanobody Discovery Service Introduction
11.2.4 Curia Revenue in Nanobody Discovery Service Business (2018-2023)
11.2.5 Curia Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Nanobody Discovery Service Introduction
11.3.4 Sanofi Revenue in Nanobody Discovery Service Business (2018-2023)
11.3.5 Sanofi Recent Development
11.4 NanoTag Biotechnologies
11.4.1 NanoTag Biotechnologies Company Detail
11.4.2 NanoTag Biotechnologies Business Overview
11.4.3 NanoTag Biotechnologies Nanobody Discovery Service Introduction
11.4.4 NanoTag Biotechnologies Revenue in Nanobody Discovery Service Business (2018-2023)
11.4.5 NanoTag Biotechnologies Recent Development
11.5 Shanghai Medicilon Inc.
11.5.1 Shanghai Medicilon Inc. Company Detail
11.5.2 Shanghai Medicilon Inc. Business Overview
11.5.3 Shanghai Medicilon Inc. Nanobody Discovery Service Introduction
11.5.4 Shanghai Medicilon Inc. Revenue in Nanobody Discovery Service Business (2018-2023)
11.5.5 Shanghai Medicilon Inc. Recent Development
11.6 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
11.6.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Detail
11.6.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
11.6.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Introduction
11.6.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Revenue in Nanobody Discovery Service Business (2018-2023)
11.6.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Development
11.7 Yeasen Biotechnology（Shanghai）Co.,Ltd.
11.7.1 Yeasen Biotechnology（Shanghai）Co.,Ltd. Company Detail
11.7.2 Yeasen Biotechnology（Shanghai）Co.,Ltd. Business Overview
11.7.3 Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Introduction
11.7.4 Yeasen Biotechnology（Shanghai）Co.,Ltd. Revenue in Nanobody Discovery Service Business (2018-2023)
11.7.5 Yeasen Biotechnology（Shanghai）Co.,Ltd. Recent Development
11.8 Fortis Life Sciences
11.8.1 Fortis Life Sciences Company Detail
11.8.2 Fortis Life Sciences Business Overview
11.8.3 Fortis Life Sciences Nanobody Discovery Service Introduction
11.8.4 Fortis Life Sciences Revenue in Nanobody Discovery Service Business (2018-2023)
11.8.5 Fortis Life Sciences Recent Development
11.9 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
11.9.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Detail
11.9.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
11.9.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Introduction
11.9.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Revenue in Nanobody Discovery Service Business (2018-2023)
11.9.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Development
11.10 Biointron Biological Inc.
11.10.1 Biointron Biological Inc. Company Detail
11.10.2 Biointron Biological Inc. Business Overview
11.10.3 Biointron Biological Inc. Nanobody Discovery Service Introduction
11.10.4 Biointron Biological Inc. Revenue in Nanobody Discovery Service Business (2018-2023)
11.10.5 Biointron Biological Inc. Recent Development
11.11 SAFE Pharmaceutical Technology Co., Ltd.
11.11.1 SAFE Pharmaceutical Technology Co., Ltd. Company Detail
11.11.2 SAFE Pharmaceutical Technology Co., Ltd. Business Overview
11.11.3 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Introduction
11.11.4 SAFE Pharmaceutical Technology Co., Ltd. Revenue in Nanobody Discovery Service Business (2018-2023)
11.11.5 SAFE Pharmaceutical Technology Co., Ltd. Recent Development
11.12 Abterra Biosciences
11.12.1 Abterra Biosciences Company Detail
11.12.2 Abterra Biosciences Business Overview
11.12.3 Abterra Biosciences Nanobody Discovery Service Introduction
11.12.4 Abterra Biosciences Revenue in Nanobody Discovery Service Business (2018-2023)
11.12.5 Abterra Biosciences Recent Development
11.13 Chengdu Apak Biotechnology Co., Ltd.
11.13.1 Chengdu Apak Biotechnology Co., Ltd. Company Detail
11.13.2 Chengdu Apak Biotechnology Co., Ltd. Business Overview
11.13.3 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Introduction
11.13.4 Chengdu Apak Biotechnology Co., Ltd. Revenue in Nanobody Discovery Service Business (2018-2023)
11.13.5 Chengdu Apak Biotechnology Co., Ltd. Recent Development
11.14 ICarTab Biomedical Co., Ltd.
11.14.1 ICarTab Biomedical Co., Ltd. Company Detail
11.14.2 ICarTab Biomedical Co., Ltd. Business Overview
11.14.3 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Introduction
11.14.4 ICarTab Biomedical Co., Ltd. Revenue in Nanobody Discovery Service Business (2018-2023)
11.14.5 ICarTab Biomedical Co., Ltd. Recent Development
11.15 Wuhan Daian Biotech Ltd
11.15.1 Wuhan Daian Biotech Ltd Company Detail
11.15.2 Wuhan Daian Biotech Ltd Business Overview
11.15.3 Wuhan Daian Biotech Ltd Nanobody Discovery Service Introduction
11.15.4 Wuhan Daian Biotech Ltd Revenue in Nanobody Discovery Service Business (2018-2023)
11.15.5 Wuhan Daian Biotech Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
